Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Suku Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Revvity | PKI - Pendapatan Penjualan
Keuangan
Harga Saham
USD
Aktiva
USD 12B
Kas Dan Setara
USD 860.32M
Biaya Penjualan
USD 323.46M
Aset Lancar
USD 2.13B
Kewajiban Lancar
USD 1.24B
UTANG
USD 3.4B
Dividen - Hasil
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
Karyawan
11K
Eps Laba Per Saham
USD 1.06
Modal Dan Cadangan
USD 7.25B
Laba Kotor Pada Penjualan
USD 387.66M
Beban Bunga Utang
USD 24.72M
Pendapatan Bunga
USD 5.75M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 13.94B
Batas Pemasukan
USD 40.72M
Biaya Operasional
USD 628.35M
Laba Operasional
USD 82.77M
Modal Saham Biasa
USD 111.8M
Pe Harga Untuk Laba
30.79
Laba Sebelum Pajak
USD 91.56M
Pendapatan Penjualan
USD 711M
Beban Penjualan Dan Administrasi
USD 253.88M
Saham
USD 387.51M
Kreditur Perdagangan
USD 169.68M
Debitur Perdagangan
USD 691.38M
Penjualan
Perubahan
Tanggal
Agilent
USD 1.84B
37M
2026-03
Align Technology
USD 1.04B
10M
2026-03
Bio Techne
USD 311.4M
15.5M
2026-03
Bio-Rad Laboratories
USD 592.1M
101.1M
2026-03
Bruker
USD 823.4M
153.8M
2026-03
Celltrion
KRW 1.15T
180B
2026-03
Charles River Laboratories
USD 995.8M
1.6M
2026-03
Cspc Pharmaceutical
CNY 6.47B
355.1M
2026-03
Danaher
USD 5.95B
890M
2026-03
Dentsply International
USD 880M
81M
2026-03
Deva Holding AS
TRY 2.32B
418.58M
2023-09
Dianthus Therapeutics
USD 463K
179K
2026-03
Divis Laboratories Ltd
INR 28.31B
2.27B
2026-03
Edwards Lifesciences
USD 1.65B
80M
2026-03
Illumina
USD 1.09B
70M
2026-03
Intuitive Surgical
USD 2.77B
100M
2026-03
IQVIA Holdings
USD 4.15B
210M
2026-03
Kangmei Pharma
CNY 1.08B
288.27M
2026-03
Knight Therapeutics
CAD 133.11M
11.56M
2025-12
Laboratorios Farma
EUR 448.66M
67.82M
2023-12
Laboratory Of America
USD 3.54B
20M
2026-03
Medical Developments International
AUD 21.57M
12.04M
2025-12
Mesa Laboratories
USD 62.84M
5.01M
2024-12
Mettler Toledo International
USD 947.13M
182.87M
2026-03
Myriad Genetics
USD 200.4M
9.4M
2026-03
Neuren Pharmaceuticals
AUD 42.24M
28.1M
2025-12
OraSure Technologies
USD 26.76M
322K
2025-12
Organigram Holdings
CAD 59.79M
3.74M
2026-03
Pacific Biosciences Of California
USD 44.64M
6.2M
2025-12
Pharma Mar
EUR 42.9M
47.3M
2026-03
Qiagen NV
USD 419.22M
38.16M
2026-03
Quest Diagnostics
USD 2.9B
90M
2026-03
Quidel
USD 620M
104M
2026-03
Repligen
USD 194M
3.91M
2026-03
Revvity
USD 711M
61.06M
2026-03
Sartorius
EUR 899.1M
28.5M
2026-03
Sino Biopharmaceutical
CNY 14.26B
3.31B
2025-12
Thermo Fisher Scientific
USD 11.01B
1.2B
2026-03
Tilray
USD 217.51M
74.75M
2025-12
Waters
USD 1.27B
338M
2026-03
Zealand Pharma A/S
68.91M
19.35M
2025-12
Zhangzhou Pientzehuang Pharmaceutical
CNY 2.72B
837.63M
2026-03
×